Catalog No.
RVV09902
Expression system
Mammalian Cells
Species reactivity
Vesicular stomatitis Indiana virus (strain San Juan) (VSIV)
Host species
Human
Isotype
IgG1, kappa
Clonality
Monoclonal
Target
NP, Nucleoprotein, Nucleocapsid protein, Protein N
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
P03521
Applications
FCM, IP, SPR
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Clone ID
1307
Single dose VSV-based vaccine protects mice against lethal heterologous Crimean-Congo hemorrhagic fever virus challenge., PMID:40447644
Short-term oral exposure to nanoplastics does not significantly impact the antiviral immune response of the mouse., PMID:39854993
A Global Collaborative Comparison of SARS-CoV-2 Antigenicity Across 15 Laboratories., PMID:39772242
Cellular and humoral immunity to Ebola Zaire glycoprotein and viral vector proteins following immunization with recombinant vesicular stomatitis virus-based Ebola vaccine (rVSVΔG-ZEBOV-GP)., PMID:36725433
A class II MHC-targeted vaccine elicits immunity against SARS-CoV-2 and its variants., PMID:34654739
Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector., PMID:30582589
Baseline mapping of Lassa fever virology, epidemiology and vaccine research and development., PMID:29581897
Analysis of the humoral immune responses among cynomolgus macaque naturally infected with Reston virus during the 1996 outbreak in the Philippines., PMID:23057674
Sustained cytoplasmic delivery and anti-viral effect of PLGA nanoparticles carrying a nucleic acid-hydrolyzing monoclonal antibody., PMID:22139535
sGP serves as a structural protein in Ebola virus infection., PMID:21987767
Recombinant vesicular stomatitis virus expressing influenza nucleoprotein induces CD8 T-cell responses that enhance antibody-mediated protection after lethal challenge with influenza virus., PMID:19244472
A pseudotype vesicular stomatitis virus containing Hantaan virus envelope glycoproteins G1 and G2 as an alternative to hantavirus vaccine in mice., PMID:16426712
Identification of a novel tripartite complex involved in replication of vesicular stomatitis virus genome RNA., PMID:12477878
Moving the glycoprotein gene of vesicular stomatitis virus to promoter-proximal positions accelerates and enhances the protective immune response., PMID:10933697
Establishment and characterisation of a porcine rubulavirus (LPMV) persistent infection in porcine kidney cells., PMID:9444775
Replication and amplification of novel vesicular stomatitis virus minigenomes encoding viral structural proteins., PMID:7707520
A small highly basic protein is encoded in overlapping frame within the P gene of vesicular stomatitis virus., PMID:8388490
Major histocompatibility complex conformational epitopes are peptide specific., PMID:1281212
Protective vaccination against bovine leukaemia virus infection by means of cell-derived vaccine., PMID:1667347
Antiviral protection by CD8+ versus CD4+ T cells. CD8+ T cells correlating with cytotoxic activity in vitro are more efficient in antivaccinia virus protection than CD4-dependent IL., PMID:1710246
Sequence analyses of the 3' genome end and NP gene of human parainfluenza type 2 virus: sequence variation of the gene-starting signal and the conserved 3' end., PMID:2173261
Tubulin: a factor necessary for the synthesis of both Sendai virus and vesicular stomatitis virus RNAs., PMID:3016702
For research use only. Not for human or drug use.
